Welcome to our searchable resource and literature collection on safer supply and related topics.
Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.
Welcome to our searchable resource and literature collection on safer supply and related topics.
Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.
Ongoing law enforcement strategies to disrupt local unregulated drug markets can have an iatrogenic effect of increasing overdose by driving consumers towards new suppliers with unpredictable drug
This study assesses the prevalence and correlates of chronic pain among primary fentanyl users.
A growing body of research details the impacts of COVID-19 pandemic-related public health directives and service disruptions on people who use unregulated drugs, however, there is limited research
This paper discusses the unique risk profile of potent, synthetic illegal drugs being packaged as counterfeit pills (as opposed to powder) in the context of overdose crises like those seen in North
People exposed to fentanyl may report that the dose of methadone in the commonly accepted therapeutic range feels too low. This paper examines self-reported methadone dose adequacy.
This study examines the recent proliferation of manslaughter charges and subsequent prosecutions brought against people who have shared, sold, or provided drugs that have led to overdose death in C
Summarizes the Timmins Summit, held in partnership with the City of Timmins.
This paper describes the results of retrospective Safer Stimulant Supply program medical chart reviews.
CCENDU, co-ordinated by the CCSA, publishes this newsletter regularly to inform people living in Canada about emerging substance use issues and trends.
This toolkit emerges from a series of virtual Community Conversations that the Drug Policy Alliance co-hosted in 2021 with key community partners: Michigan Users Union, New England Users Union, Nat
This is a practice brief specific to AVI Health & Community Services prescribed alternatives program and service model in British Columbia.
We aimed to describe buprenorphine injection intended for sublingual use by rural people who inject drugs to inform patient-clinician discussions and public health in
Concerns around excessive opioid prescribing have been used to argue against the expansion of the scope of practice of nurse practitioners (NPs), but the association of NP practice independence wit
This commentary explores a recent shift in British Columbia's drug policy under a novel drug “decriminalization” framework in the context of a severe crisis of drug-related overdoses and poisonings
The emergence of xylazine into the U.S. drug supply has increased demand for wound care services among people who inject drugs (PWID).
This study aimed to determine the prevalence of non-substance use-related mental health emergency department (ED) visits, hospitalizations, and outpatient physician visits for individuals receiving
To examine neuroanatomical features associated with early substance use initiation and to what extent associations may reflect preexisting vulnerability.